These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7621563)

  • 1. Adrenarche does not occur in treated patients with congenital adrenal hyperplasia resulting from 21-hydroxylase deficiency.
    Brunelli VL; Chiumello G; David M; Forest MG
    Clin Endocrinol (Oxf); 1995 May; 42(5):461-6. PubMed ID: 7621563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 'Exaggerated adrenarche' in children presenting with premature adrenarche.
    Likitmaskul S; Cowell CT; Donaghue K; Kreutzmann DJ; Howard NJ; Blades B; Silink M
    Clin Endocrinol (Oxf); 1995 Mar; 42(3):265-72. PubMed ID: 7758231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted adrenarche in patients with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Sellers EP; MacGillivray MH
    Endocr Res; 1995 Aug; 21(3):537-44. PubMed ID: 7588424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenarche and puberty in children with classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Völkl TM; Öhl L; Rauh M; Schöfl C; Dörr HG
    Horm Res Paediatr; 2011; 76(6):400-10. PubMed ID: 22123283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of late-onset adrenal hyperplasia in girls with peripubertal virilization.
    Sólyom J; Gács G; Keszei K; Láng K; Orley J; Petheö I; Ságodi L
    Acta Endocrinol (Copenh); 1987 Jul; 115(3):413-8. PubMed ID: 3039770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 17-Hydroxyprogesterone responses to adrenocorticotropin in children with premature adrenarche.
    Granoff AB; Chasalow FI; Blethen SL
    J Clin Endocrinol Metab; 1985 Mar; 60(3):409-15. PubMed ID: 2982895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of nonclassical congenital adrenal hyperplasia in patients with precocious adrenarche.
    Morris AH; Reiter EO; Geffner ME; Lippe BM; Itami RM; Mayes DM
    J Clin Endocrinol Metab; 1989 Oct; 69(4):709-15. PubMed ID: 2550505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3 beta-hydroxysteroid dehydrogenase deficiency in hyperandrogenism.
    Azziz R; Bradley EL; Potter HD; Boots LR
    Am J Obstet Gynecol; 1993 Mar; 168(3 Pt 1):889-95. PubMed ID: 8456898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alternate day prednisone therapy in congenital adrenal hyperplasia: adrenal androgen suppression and normal growth.
    Linder B; Feuillan P; Chrousos GP
    J Clin Endocrinol Metab; 1989 Jul; 69(1):191-5. PubMed ID: 2543690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of and markers for the attenuated form of congenital adrenal hyperplasia and hyperprolactinemia masquerading as polycystic ovarian disease.
    Benjamin F; Deutsch S; Saperstein H; Seltzer VL
    Fertil Steril; 1986 Aug; 46(2):215-21. PubMed ID: 3015693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disproportionate suppression of dehydroepiandrosterone sulfate (DHEAS) in treated patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Rezvani I; Garibaldi LR; Digeorge AM; Artman HG
    Pediatr Res; 1983 Feb; 17(2):131-4. PubMed ID: 6219334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of a Leydig cell tumor presenting as congenital adrenal hyperplasia.
    Solish SB; Goldsmith MA; Voutilainen R; Miller WL
    J Clin Endocrinol Metab; 1989 Dec; 69(6):1148-52. PubMed ID: 2555382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pituitary-ovarian responses to leuprolide acetate testing in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
    Ghizzoni L; Virdis R; Vottero A; Cappa M; Street ME; Zampolli M; Ibañez L; Bernasconi S
    J Clin Endocrinol Metab; 1996 Feb; 81(2):601-6. PubMed ID: 8636275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolated precocious pubarche: an approach.
    Balducci R; Boscherini B; Mangiantini A; Morellini M; Toscano V
    J Clin Endocrinol Metab; 1994 Aug; 79(2):582-9. PubMed ID: 8045980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary-adrenal axis activity in treated congenital adrenal hyperplasia: static and dynamic studies.
    Pham-Huu-Trung MT; Gourmelen M; Raux-Eurin MC; Girard F
    J Clin Endocrinol Metab; 1978 Aug; 47(2):422-7. PubMed ID: 233672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthropometric and endocrine features in girls with isolated premature pubarche or non-classical congenital adrenal hyperplasia.
    Accetta SG; Di Domênico K; Ritter CG; Ritter AT; Capp E; Spritzer PM
    J Pediatr Endocrinol Metab; 2004 May; 17(5):767-73. PubMed ID: 15237712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced serum levels of dehydroepiandrosterone sulphate in adrenal incidentalomas: a marker of adrenocortical tumour.
    Flecchia D; Mazza E; Carlini M; Blatto A; Olivieri F; Serra G; Camanni F; Messina M
    Clin Endocrinol (Oxf); 1995 Feb; 42(2):129-34. PubMed ID: 7704956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Precocious pubarche: distinguishing late-onset congenital adrenal hyperplasia from premature adrenarche.
    Armengaud JB; Charkaluk ML; Trivin C; Tardy V; Bréart G; Brauner R; Chalumeau M
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2835-40. PubMed ID: 19454583
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACTH stimulation tests and plasma dehydroepiandrosterone sulfate levels in women with hirsutism.
    Siegel SF; Finegold DN; Lanes R; Lee PA
    N Engl J Med; 1990 Sep; 323(13):849-54. PubMed ID: 2168515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of three glucocorticoid suppressive regimes in adults with congenital adrenal hyperplasia.
    Horrocks PM; London DR
    Clin Endocrinol (Oxf); 1982 Dec; 17(6):547-56. PubMed ID: 6299623
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.